Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Agilon Health (AGL) Leases (2020 - 2025)

Agilon Health's Leases history spans 6 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Leases fell 59.67% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 59.67%, while the annual FY2025 figure was $3.5 million, 59.67% down from the prior year.
  • Leases reached $3.5 million in Q4 2025 per AGL's latest filing, down from $3.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $14.6 million in Q3 2023 to a low of $3.5 million in Q4 2025.
  • Average Leases over 5 years is $11.0 million, with a median of $12.0 million recorded in 2022.
  • Peak YoY movement for Leases: increased 22.47% in 2021, then plummeted 65.76% in 2025.
  • A 5-year view of Leases shows it stood at $11.7 million in 2021, then increased by 2.36% to $12.0 million in 2022, then increased by 11.61% to $13.4 million in 2023, then tumbled by 34.51% to $8.8 million in 2024, then plummeted by 59.67% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Leases are $3.5 million (Q4 2025), $3.9 million (Q3 2025), and $8.8 million (Q2 2025).